Vol 13: Paliperidone extended release for the treatment of pediatric and adolescent patients with Tourettes disorder.Report as inadecuate



 Vol 13: Paliperidone extended release for the treatment of pediatric and adolescent patients with Tourettes disorder.


Vol 13: Paliperidone extended release for the treatment of pediatric and adolescent patients with Tourettes disorder. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 13: Paliperidone extended release for the treatment of pediatric and adolescent patients with Tourettes disorder.
This article is from Annals of General Psychiatry, volume 13.AbstractObjective: A subgroup of patients with Tourettes disorder TD has symptoms refractory to haloperidol, a standard therapeutic drug for TD. Methods: We report on three cases of pediatric and adolescent patients who were treated with paliperidone extended release. Results: In two cases, TD symptoms were remarkably improved by switching from haloperidol to paliperidone extended release, and in another case, paliperidone extended release showed significant efficacy in treating TD symptoms as the first-line drug. In all cases, no significant adverse side effects were detected. Conclusion: Paliperidone extended release may be a strong candidate for the treatment of pediatric and adolescent patients with TD.



Author: Yamamuro, Kazuhiko; Makinodan, Manabu; Ota, Toyosaku; Iida, Junzo; Kishimoto, Toshifumi

Source: https://archive.org/







Related documents